Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 5;46(3 Suppl 1):e20230103.
doi: 10.1590/1678-4685-GMB-2023-0103. eCollection 2024.

Homocysteine and methylmalonic acid in Phenylketonuria patients

Affiliations

Homocysteine and methylmalonic acid in Phenylketonuria patients

Giovana Regina Weber Hoss et al. Genet Mol Biol. .

Abstract

Hyperhomocysteinemia and vitamin B12 deficiency have been reported in patients with phenylketonuria. In this study, total homocysteine (tHcy) and methylmalonic acid (MMA) levels were analyzed in samples from 25 phenylketonuria (PKU) patients. Comparisons were made between pre- and post-treatment values (n= 3); on treatment values, between periods with high and normal/low phenylalanine (Phe) levels (n= 20); and in women before, during and after pregnancy (n= 3). THcy levels decreased after treating PKU with metabolic formula (p=0.014). Except for a pregnant woman before pregnancy, none of the patients had tHcy values above the normal range. In fact, tHcy was < 5 μmol/L in 34% of the samples. We observed a decrease in Phe, tHcy, and tyrosine levels during pregnancy. MMA levels did not differ significantly, with values remaining in the normal range. These data indicate that there was no B12 deficiency in patients who adhere to the diet. In conclusion, in PKU patients treated with metabolic formula, tHcy is frequently not elevated, remaining even in the lower normal range in some patients. Thus, clinical follow-up and adherence to dietary treatment are crucial to prevent B12 deficiency.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors declare they have no conflicts of interest that could be perceived as prejudicial to the impartiality of the study.

Figures

Figure 1 -
Figure 1 -. Total homocysteine and methylmalonic acid in PKU patients before and after treatment.

Similar articles

Cited by

References

    1. Akış M, Kant M, Işık İ, Kısa PT, Köse E, Arslan N, İşlekel H. Functional vitamin B12 deficiency in phenylketonuria patients and healthy controls: An evaluation with combined indicator of vitamin B12 status as a biochemical index. Ann Clin Biochem. 2020;57:291–299. - PubMed
    1. Andrade F, López-Suárez O, Llarena M, Couce ML, Aldámiz-Echevarría L. Influence of phenylketonuria’s diet on dimethylated arginines and methylation cycle. Medicine (Baltimore) 2017;96:e7392. - PMC - PubMed
    1. Bártl J, Chrastina P, Krijt J, Hodík J, Pešková K, Kožich V. Simultaneous determination of cystathionine, total homocysteine, and methionine in dried blood spots by liquid chromatography/tandem mass spectrometry and its utility for the management of patients with homocystinuria. Clin Chim Acta. 2014;437:211–217. - PubMed
    1. Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet. 2010;376:1417–1427. - PubMed
    1. Blom HJ, van Rooij A, Hogeveen M. A simple high-throughput method for the determination of plasma methylmalonic acid by liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med. 2007;45:645–650. - PubMed